3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 31.70
+0.64 (2.06%)
Sep 3, 2025, 11:45 AM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 74.29 billion as of September 2, 2025. Its market cap has increased by 408.77% in one year.
Market Cap
74.29B
Enterprise Value
72.14B
Revenue
9.94B
Ranking
n/a
PE Ratio
29.56
Stock Price
31.70
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 74.29B, an increase of 227.74%. That is a compound annual growth rate of 12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 74.29B | 418.81% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | 17.98B | -29.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 262.49B |
| Hansoh Pharmaceutical Group Company | 218.06B |
| JD Health International | 201.05B |
| Innovent Biologics | 165.88B |
| Sino Biopharmaceutical | 145.04B |
| Akeso | 139.76B |
| WuXi Biologics | 135.14B |
| CSPC Pharmaceutical Group | 115.13B |